Health Care | Biotech | Pharmaceuticals 2025: DR. MITCHELL ROSNER

A nephrologist who joined the University of Virginia’s medical school as a professor in 2005, Rosner stepped in as interim executive vice president for health affairs in February. His predecessor, Dr. K. Craig Kent, resigned after an investigation into allegations in a letter of “no confidence” signed by 128 physicians in 2024.

Despite Kent’s departure, Rosner has dealt with multiple challenges in recent months, including sparring between former and current health system board officials and medical school faculty members, as well as the departures of Dr. Melina Kibbe, the medical school’s dean, and the CEO of the U.Va. Medical Center. In his role, Rosner oversees UVA Health, which includes the medical center, three community hospitals and regional clinics.

Meanwhile, though, the university is building the $350 million Paul and Diane Manning Institute of Biotechnology, working to develop cures for cancer and neurodegenerative diseases. The institute’s 350,000-square-foot facility is under construction, with completion expected in 2027.

ADVICE FOR NEW COLLEGE GRADS: Be open to new experiences, embrace change, build strong relationships and continuously learn.

MOST VALUED POSSESSION: 1969 New York Mets baseball card set

Return to the full list of this category’s recipients.